Exane Derivatives Zimmer Biomet Holdings, Inc. Transaction History

Exane Derivatives

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$102.23 - $133.85 $204 - $267	-2 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$108.42 - $129.58 $216 - $259	2 New	2 $0
Q4 2021 Jan 28, 2022	SELL	$115.43 - $146.63 $230 - $293	-2 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$148.16 - $159.71 $5,037 - $5,430	-34 Reduced 94.44%	2 $0
Q4 2020 Jan 27, 2021	SELL	$128.25 - $151.41 $52,326 - $61,775	-408 Reduced 91.89%	36 $5,000
Q3 2020 Oct 08, 2020	BUY	$113.59 - $141.68 $50,433 - $62,905	444 New	444 $58,000
Q3 2020 Oct 06, 2020	SELL	$113.59 - $141.68 $50,433 - $62,905	-444 Closed	0 $0
Q2 2020 Jul 10, 2020	SELL	$87.02 - $133.4 $114,692 - $175,821	-1,318 Reduced 74.8%	444 $51,000
Q1 2020 Apr 17, 2020	SELL	$78.28 - $155.73 $91,979 - $182,982	-1,175 Reduced 40.01%	1,762 $172,000
Q4 2019 Jan 22, 2020	BUY	$127.4 - $146.83 $374,173 - $431,239	2,937 New	2,937 $426,000

1,081

179M

301K

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $23.3B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.